We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen, Arrakis Join Forces to Attack Disease-Causing RNA
Amgen, Arrakis Join Forces to Attack Disease-Causing RNA
Amgen and Arrakis Therapeutics have teamed up to develop targeted RNA degraders, an entirely new class of therapeutic molecules designed to destroy disease-causing RNA.